Cite
HARVARD Citation
Powles, T. et al. (2021). Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma. Journal of clinical oncology. 39 (30), pp. 3411-3412. [Online].